$JNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in JUNIPER PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in JUNIPER PHARMACEUTICALS INC. Get notifications about new insider transactions in JUNIPER PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Option Exercise | D | 7.51 | 70,000 | 525,700 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Option Exercise | D | 5.15 | 30,000 | 154,500 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Sell | D | 11.50 | 80,747 | 928,591 | 0 | 80.7 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Sell | D | 11.50 | 36,109 | 415,254 | 0 | 36.1 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | GOOD JENNIFER L | Director | Sell | D | 11.50 | 15,000 | 172,500 | 0 | 15 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | GRAY MARY ANN | Director | Sell | D | 11.50 | 16,244 | 186,806 | 0 | 16.2 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MERRIFIELD C ANN | Director | Sell | D | 11.50 | 24,103 | 277,185 | 0 | 24.1 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 100,000 | 1,150,000 | 0 | 100 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 875 | 10,063 | 0 | 875 to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 6,250 | 71,875 | 0 | 6.3 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 28,000 | 322,000 | 0 | 28 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 2,001 | 23,012 | 0 | 2 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 14,500 | 166,750 | 0 | 14.5 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 41,000 | 471,500 | 0 | 41 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 9,700 | 111,550 | 0 | 9.7 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 8,000 | 92,000 | 0 | 8 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 250 | 2,875 | 0 | 250 to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 250 | 2,875 | 0 | 250 to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 250 | 2,875 | 0 | 250 to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Sell | D | 11.50 | 13,657 | 157,056 | 0 | 13.7 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | M | 7.05 | 32,000 | 225,600 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | M | 5.56 | 32,000 | 177,920 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | M | 7.82 | 50,000 | 391,000 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | M | 5.15 | 53,000 | 272,950 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | M | 4.05 | 10,000 | 40,500 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | M | 7.90 | 40,000 | 316,000 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Grant | A | 11.50 | 10,500 | 120,750 | 328,461 | 339 K to 328.5 K (-3.10 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Payment of Exercise | F | 11.50 | 123,823 | 1,423,965 | 317,961 | 441.8 K to 318 K (-28.03 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Buy | M | 7.05 | 32,000 | 225,600 | 441,784 | 409.8 K to 441.8 K (+7.81 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Buy | M | 5.56 | 32,000 | 177,920 | 409,784 | 377.8 K to 409.8 K (+8.47 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Buy | M | 7.82 | 50,000 | 391,000 | 377,784 | 327.8 K to 377.8 K (+15.25 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Buy | M | 5.15 | 53,000 | 272,950 | 327,784 | 274.8 K to 327.8 K (+19.29 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Buy | M | 4.05 | 10,000 | 40,500 | 274,784 | 264.8 K to 274.8 K (+3.78 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Buy | M | 7.90 | 40,000 | 316,000 | 264,784 | 224.8 K to 264.8 K (+17.79 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | D | 7.59 | 225,000 | 1,707,750 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | D | 5.15 | 127,500 | 656,625 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | D | 7.90 | 110,000 | 869,000 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Sell | D | 11.50 | 103,855 | 1,194,333 | 0 | 103.9 K to 0 (-100.00 %) |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Young Jeffrey E | Chief Financial Off ... | Option Exercise | D | 5.60 | 170,000 | 952,000 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Young Jeffrey E | Chief Financial Off ... | Option Exercise | D | 7.90 | 40,000 | 316,000 | 0 | |
Aug 15 2018 | JNP | JUNIPER PHARMACEUT ... | Young Jeffrey E | Chief Financial Off ... | Sell | D | 11.50 | 30,413 | 349,750 | 0 | 30.4 K to 0 (-100.00 %) |
Mar 22 2018 | JNP | JUNIPER PHARMACEUT ... | MESSINA RICHARD | Director | Grant | A | 0.00 | 5,625 | 0 | 13,657 | 8 K to 13.7 K (+70.03 %) |
Mar 06 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Payment of Exercise | F | 8.80 | 1,870 | 16,456 | 86,355 | 88.2 K to 86.4 K (-2.12 %) |
Feb 09 2018 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Grant | A | 0.00 | 6,000 | 0 | 206,384 | 200.4 K to 206.4 K (+2.99 %) |
Feb 09 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Payment of Exercise | F | 8.40 | 3,475 | 29,190 | 37,725 | 41.2 K to 37.7 K (-8.43 %) |
Feb 09 2018 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Grant | A | 0.00 | 10,000 | 0 | 41,200 | 31.2 K to 41.2 K (+32.05 %) |
Feb 09 2018 | JNP | JUNIPER PHARMACEUT ... | Young Jeffrey E | Chief Financial Off ... | Payment of Exercise | F | 8.40 | 1,737 | 14,591 | 3,263 | 5 K to 3.3 K (-34.74 %) |
Feb 09 2018 | JNP | JUNIPER PHARMACEUT ... | Young Jeffrey E | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Sep 11 2017 | JNP | JUNIPER PHARMACEUT ... | GOOD JENNIFER L | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Apr 13 2017 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | A | 4.05 | 10,000 | 40,500 | 10,000 | |
Mar 20 2017 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Buy | P | 4.82 | 2,000 | 9,637 | 65,153 | 63.2 K to 65.2 K (+3.17 %) |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Option Exercise | A | 5.15 | 30,000 | 154,500 | 30,000 | |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Option Exercise | A | 5.15 | 53,000 | 272,950 | 53,000 | |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | Chief Operating Off ... | Grant | A | 0.00 | 11,000 | 0 | 200,384 | 189.4 K to 200.4 K (+5.81 %) |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Martell Bridget A | Chief Medical Offic ... | Option Exercise | A | 5.15 | 74,900 | 385,735 | 74,900 | |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Martell Bridget A | Chief Medical Offic ... | Grant | A | 0.00 | 15,500 | 0 | 15,500 | 0 to 15.5 K |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Option Exercise | A | 5.15 | 127,500 | 656,625 | 127,500 | |
Mar 07 2017 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Grant | A | 0.00 | 26,200 | 0 | 31,200 | 5 K to 31.2 K (+524.00 %) |
Jan 05 2017 | JNP | JUNIPER PHARMACEUT ... | Young Jeffrey E | Chief Financial Off ... | Option Exercise | A | 5.60 | 170,000 | 952,000 | 170,000 | |
Sep 14 2016 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Buy | P | 5.97 | 2,000 | 11,930 | 63,153 | 61.2 K to 63.2 K (+3.27 %) |
Aug 31 2016 | JNP | JUNIPER PHARMACEUT ... | Elston George | Chief Financial Off ... | Buy | P | 5.50 | 1,000 | 5,500 | 1,000 | 0 to 1,000 |
Aug 29 2016 | JNP | JUNIPER PHARMACEUT ... | Secor Alicia | President and CEO | Buy | P | 5.75 | 5,000 | 28,750 | 5,000 | 0 to 5 K |
Aug 29 2016 | JNP | JUNIPER PHARMACEUT ... | MERRIFIELD C ANN | Director | Buy | P | 5.63 | 2,000 | 11,260 | 15,193 | 13.2 K to 15.2 K (+15.16 %) |
Aug 24 2016 | JNP | JUNIPER PHARMACEUT ... | ARMSTRONG FRANK M | Director | Buy | P | 6.16 | 1,623 | 9,994 | 19,928 | 18.3 K to 19.9 K (+8.87 %) |
Aug 24 2016 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Buy | P | 6.03 | 2,937 | 17,716 | 61,153 | 58.2 K to 61.2 K (+5.05 %) |
Aug 24 2016 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Buy | P | 5.90 | 4,063 | 23,972 | 58,216 | 54.2 K to 58.2 K (+7.50 %) |
Aug 03 2016 | JNP | JUNIPER PHARMACEUT ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 6,064 | 0 | 7,334 | 1.3 K to 7.3 K (+477.48 %) |
Aug 03 2016 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Grant | A | 0.00 | 10,613 | 0 | 54,153 | 43.5 K to 54.2 K (+24.38 %) |
Aug 03 2016 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Grant | A | 0.00 | 6,064 | 0 | 27,199 | 21.1 K to 27.2 K (+28.69 %) |
Aug 03 2016 | JNP | JUNIPER PHARMACEUT ... | ARMSTRONG FRANK M | Director | Grant | A | 0.00 | 6,064 | 0 | 18,305 | 12.2 K to 18.3 K (+49.54 %) |
Aug 03 2016 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | Director | Grant | A | 0.00 | 6,064 | 0 | 85,784 | 79.7 K to 85.8 K (+7.61 %) |
Aug 03 2016 | JNP | JUNIPER PHARMACEUT ... | MERRIFIELD C ANN | Director | Grant | A | 0.00 | 6,064 | 0 | 13,193 | 7.1 K to 13.2 K (+85.06 %) |
Jul 06 2016 | JNP | JUNIPER PHARMACEUT ... | Elston George | Chief Financial Off ... | Option Exercise | A | 7.82 | 50,000 | 391,000 | 50,000 | |
Jul 06 2016 | JNP | JUNIPER PHARMACEUT ... | Martell Bridget A | Chief Medical Offic ... | Option Exercise | A | 7.82 | 50,000 | 391,000 | 50,000 | |
Jul 06 2016 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | COO | Option Exercise | A | 7.82 | 50,000 | 391,000 | 50,000 | |
Jul 06 2016 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Option Exercise | A | 7.82 | 110,000 | 860,200 | 110,000 | |
Apr 06 2016 | JNP | JUNIPER PHARMACEUT ... | GRAY MARY ANN | Director | Grant | A | 0.00 | 1,270 | 0 | 1,270 | 0 to 1.3 K |
Dec 08 2015 | JNP | JUNIPER PHARMACEUT ... | MERRIFIELD C ANN | Director | Buy | P | 12.14 | 1,600 | 19,421 | 7,129 | 5.5 K to 7.1 K (+28.94 %) |
Nov 20 2015 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | COO | Buy | P | 11.88 | 4,300 | 51,101 | 189,384 | 185.1 K to 189.4 K (+2.32 %) |
Nov 20 2015 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | COO | Buy | P | 11.45 | 700 | 8,016 | 185,084 | 184.4 K to 185.1 K (+0.38 %) |
Nov 19 2015 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Buy | P | 11.75 | 8,000 | 94,000 | 43,079 | 35.1 K to 43.1 K (+22.81 %) |
Nov 19 2015 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Buy | P | 11.68 | 5,000 | 58,402 | 79,720 | 74.7 K to 79.7 K (+6.69 %) |
Oct 30 2015 | JNP | JUNIPER PHARMACEUT ... | MERRIFIELD C ANN | Director | Grant | A | 0.00 | 2,529 | 0 | 5,529 | 3 K to 5.5 K (+84.30 %) |
Oct 30 2015 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Grant | A | 0.00 | 2,529 | 0 | 35,079 | 32.6 K to 35.1 K (+7.77 %) |
Oct 30 2015 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Grant | A | 0.00 | 2,529 | 0 | 21,135 | 18.6 K to 21.1 K (+13.59 %) |
Oct 30 2015 | JNP | JUNIPER PHARMACEUT ... | ARMSTRONG FRANK M | Director | Grant | A | 0.00 | 2,529 | 0 | 12,241 | 9.7 K to 12.2 K (+26.04 %) |
Oct 30 2015 | JNP | JUNIPER PHARMACEUT ... | HUNTER DONALD H | Director | Grant | A | 0.00 | 2,529 | 0 | 8,827 | 6.3 K to 8.8 K (+40.16 %) |
Aug 17 2015 | JNP | JUNIPER PHARMACEUT ... | MERRIFIELD C ANN | Director | Buy | P | 9.87 | 2,000 | 19,740 | 3,000 | 1,000 to 3 K (+200.00 %) |
Aug 17 2015 | JNP | JUNIPER PHARMACEUT ... | MERRIFIELD C ANN | Director | Buy | P | 9.96 | 1,000 | 9,960 | 1,000 | 0 to 1,000 |
Aug 10 2015 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Buy | P | 10.46 | 12,000 | 125,520 | 33,011 | 21 K to 33 K (+57.11 %) |
Jun 16 2015 | JNP | JUNIPER PHARMACEUT ... | ARMSTRONG FRANK M | Director | Buy | P | 7.95 | 1,255 | 9,982 | 5,146 | 3.9 K to 5.1 K (+32.25 %) |
Jun 11 2015 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | COO | Buy | P | 7.52 | 13,500 | 101,520 | 184,384 | 170.9 K to 184.4 K (+7.90 %) |
Jun 02 2015 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Buy | P | 8.38 | 20,550 | 172,209 | 0 | -20,550 to 0 (-100.00 %) |
Jun 01 2015 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Option Exercise | A | 7.51 | 70,000 | 525,700 | 70,000 | |
Jun 01 2015 | JNP | JUNIPER PHARMACEUT ... | GERAGHTY JAMES A | Director | Grant | A | 7.51 | 461 | 3,462 | 461 | 0 to 461 |
May 12 2015 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Option Exercise | M | 4.95 | 9,375 | 46,406 | 9,375 | |
May 12 2015 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Buy | M | 4.95 | 9,375 | 46,406 | 74,720 | 65.3 K to 74.7 K (+14.35 %) |
May 11 2015 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Buy | P | 7.36 | 10,000 | 73,600 | 65,345 | 55.3 K to 65.3 K (+18.07 %) |
Feb 19 2015 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | CEO, Molecular Prof ... | Option Exercise | A | 5.56 | 32,000 | 177,920 | 32,000 | |
Feb 19 2015 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Option Exercise | A | 5.56 | 40,000 | 222,400 | 40,000 | |
Jan 09 2015 | JNP | JUNIPER PHARMACEUT ... | Martell Bridget A | Chief Medical Offic ... | Option Exercise | A | 5.63 | 60,000 | 337,800 | 60,000 | |
Nov 24 2014 | JNP | JUNIPER PHARMACEUT ... | HUNTER DONALD H | Director | Buy | P | 5.98 | 1,000 | 5,980 | 1,732 | 732 to 1.7 K (+136.61 %) |
Oct 03 2014 | JNP | JUNIPER PHARMACEUT ... | Elston George | Chief Financial Off ... | Option Exercise | A | 5.97 | 75,000 | 447,750 | 75,000 | |
Aug 14 2014 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Buy | P | 5.98 | 10,000 | 59,800 | 55,345 | 45.3 K to 55.3 K (+22.05 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 6.57 | 3,024 | 19,868 | 17,752 | 20.8 K to 17.8 K (-14.56 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 4,566 | 46 | 17,752 | 13.2 K to 17.8 K (+34.63 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 6.57 | 3,024 | 19,868 | 18,201 | 21.2 K to 18.2 K (-14.25 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 4,566 | 46 | 30,319 | 25.8 K to 30.3 K (+17.73 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Payment of Exercise | F | 6.57 | 2,419 | 15,893 | 30,319 | 32.7 K to 30.3 K (-7.39 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Payment of Exercise | F | 6.57 | 2,117 | 13,909 | 18,606 | 20.7 K to 18.6 K (-10.22 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Grant | A | 0.01 | 4,566 | 46 | 18,606 | 14 K to 18.6 K (+32.52 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | ARMSTRONG FRANK M | Director | Grant | A | 0.01 | 4,566 | 46 | 8,457 | 3.9 K to 8.5 K (+117.35 %) |
May 13 2014 | JNP | JUNIPER PHARMACEUT ... | HUNTER DONALD H | Director | Grant | A | 0.01 | 4,566 | 46 | 5,298 | 732 to 5.3 K (+623.77 %) |
May 05 2014 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Buy | P | 6.65 | 10,000 | 66,500 | 45,345 | 35.3 K to 45.3 K (+28.29 %) |
May 05 2014 | JNP | JUNIPER PHARMACEUT ... | LLOYD JONES JONATHAN BRIAN | Vice President & CF ... | Option Exercise | M | 5.04 | 1,000 | 5,040 | 22,000 | |
May 05 2014 | JNP | JUNIPER PHARMACEUT ... | LLOYD JONES JONATHAN BRIAN | Vice President & CF ... | Buy | M | 5.04 | 1,000 | 5,040 | 5,580 | 4.6 K to 5.6 K (+21.83 %) |
Mar 12 2014 | JNP | JUNIPER PHARMACEUT ... | LLOYD JONES JONATHAN BRIAN | Vice President & CF ... | Option Exercise | A | 7.05 | 30,000 | 211,500 | 30,000 | |
Mar 12 2014 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Option Exercise | A | 7.05 | 40,000 | 282,000 | 40,000 | |
Mar 11 2014 | JNP | JUNIPER PHARMACEUT ... | Actavis plc | 10% Owner | Sell | S | 5.76 | 1,400,000 | 8,064,000 | 0 | 1.4 M to 0 (-100.00 %) |
Mar 11 2014 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | CEO, Molecular Prof ... | Option Exercise | A | 7.05 | 32,000 | 225,600 | 32,000 | |
Mar 12 2014 | JNP | JUNIPER PHARMACEUT ... | LLOYD JONES JONATHAN BRIAN | Vice President & CF ... | Option Exercise | M | 5.04 | 2,000 | 10,080 | 23,000 | |
Mar 12 2014 | JNP | JUNIPER PHARMACEUT ... | LLOYD JONES JONATHAN BRIAN | Vice President & CF ... | Buy | M | 5.04 | 2,000 | 10,080 | 4,580 | 2.6 K to 4.6 K (+77.52 %) |
Mar 05 2014 | JNP | JUNIPER PHARMACEUT ... | HUNTER DONALD H | Director | Grant | A | 6.83 | 732 | 5,000 | 732 | 0 to 732 |
Nov 26 2013 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Buy | P | 6.32 | 5,000 | 31,600 | 35,346 | 30.3 K to 35.3 K (+16.48 %) |
Nov 26 2013 | JNP | JUNIPER PHARMACEUT ... | LLOYD JONES JONATHAN BRIAN | Vice President & CF ... | Buy | P | 6.32 | 1,580 | 9,986 | 2,580 | 1,000 to 2.6 K (+158.00 %) |
Oct 01 2013 | JNP | JUNIPER PHARMACEUT ... | ARMSTRONG FRANK M | Director | Grant | A | 7.71 | 3,891 | 30,000 | 3,891 | 0 to 3.9 K |
Sep 23 2013 | JNP | JUNIPER PHARMACEUT ... | Patel Nikin | CEO, Molecular Prof ... | Grant | A | 0.00 | 170,884 | 0 | 170,884 | 0 to 170.9 K |
Jul 01 2013 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Payment of Exercise | F | 0.62 | 15,441 | 9,573 | 169,803 | 185.2 K to 169.8 K (-8.34 %) |
Jul 01 2013 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Payment of Exercise | F | 0.62 | 17,647 | 10,941 | 225,380 | 243 K to 225.4 K (-7.26 %) |
Jul 01 2013 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 0.62 | 17,647 | 10,941 | 129,688 | 147.3 K to 129.7 K (-11.98 %) |
May 15 2013 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Buy | P | 0.63 | 80,000 | 50,720 | 242,764 | 162.8 K to 242.8 K (+49.15 %) |
May 14 2013 | JNP | JUNIPER PHARMACEUT ... | LLOYD JONES JONATHAN BRIAN | Vice President & CF ... | Buy | P | 0.63 | 8,000 | 5,000 | 8,000 | 0 to 8 K |
May 03 2013 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 48,387 | 484 | 129,688 | 81.3 K to 129.7 K (+59.52 %) |
May 03 2013 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Grant | A | 0.01 | 48,387 | 484 | 169,803 | 121.4 K to 169.8 K (+39.85 %) |
May 03 2013 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Grant | A | 0.01 | 48,387 | 484 | 129,261 | 80.9 K to 129.3 K (+59.83 %) |
May 03 2013 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 48,387 | 484 | 225,380 | 177 K to 225.4 K (+27.34 %) |
Mar 05 2013 | JNP | JUNIPER PHARMACEUT ... | CONDELLA FRANK JR | President & CEO | Option Exercise | A | 0.62 | 300,000 | 186,000 | 300,000 | |
Jun 11 2012 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 44,117 | 441 | 98,948 | 54.8 K to 98.9 K (+80.46 %) |
Jun 11 2012 | JNP | JUNIPER PHARMACEUT ... | BLECHSCHMIDT EDWARD A | Director | Grant | A | 0.01 | 44,117 | 441 | 136,587 | 92.5 K to 136.6 K (+47.71 %) |
Jun 11 2012 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Grant | A | 0.01 | 44,117 | 441 | 80,874 | 36.8 K to 80.9 K (+120.02 %) |
Jun 11 2012 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 44,117 | 441 | 194,640 | 150.5 K to 194.6 K (+29.31 %) |
Mar 01 2012 | JNP | JUNIPER PHARMACEUT ... | Gyenes Lawrence A | Senior Vice Preside ... | Option Exercise | A | 0.66 | 135,000 | 89,100 | 135,000 | |
Mar 01 2012 | JNP | JUNIPER PHARMACEUT ... | MCGRANE MICHAEL | Senior Vice Preside ... | Option Exercise | A | 0.66 | 135,000 | 89,100 | 135,000 | |
Mar 01 2012 | JNP | JUNIPER PHARMACEUT ... | Creasy George William II | Vice President | Option Exercise | A | 0.66 | 90,000 | 59,400 | 90,000 | |
Mar 01 2012 | JNP | JUNIPER PHARMACEUT ... | COLUMBIA LABORATORIES INC | President and CEO | Option Exercise | A | 0.66 | 315,000 | 207,900 | 315,000 | |
May 05 2011 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Grant | A | 0.01 | 8,720 | 87 | 150,523 | 141.8 K to 150.5 K (+6.15 %) |
May 05 2011 | JNP | JUNIPER PHARMACEUT ... | KASNET STEPHEN G | Director | Payment of Exercise | F | 3.44 | 11,215 | 38,580 | 141,803 | 153 K to 141.8 K (-7.33 %) |
May 05 2011 | JNP | JUNIPER PHARMACEUT ... | Csimma Cristina | Director | Grant | A | 0.01 | 8,720 | 87 | 36,757 | 28 K to 36.8 K (+31.10 %) |
May 05 2011 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Grant | A | 0.01 | 8,720 | 87 | 54,831 | 46.1 K to 54.8 K (+18.91 %) |
May 05 2011 | JNP | JUNIPER PHARMACEUT ... | Andrews Valerie Lynne | Director | Payment of Exercise | F | 3.44 | 11,215 | 38,580 | 46,111 | 57.3 K to 46.1 K (-19.56 %) |